After PCI and 3 mo of DAPT, P2Y12-inhibitor monotherapy was noninferior to DAPT at 12 mo

Alexander Gallus

doi:10.7326/ACPJ201911190-053

After PCI and 3 mo of DAPT, P2Y12-inhibitor monotherapy was noninferior to DAPT at 12 mo

Alexander Gallus

Flinders University

Research output: Contribution to journal › Comment/debate

1 Citation (Scopus)

Abstract

Question
After percutaneous coronary intervention (PCI) and 3 months of dual-antiplatelet therapy (DAPT), is P2Y12-inhibitor monotherapy noninferior to continued DAPT?

Original language	English
Pages (from-to)	JC53
Number of pages	1
Journal	Annals of Internal Medicine
Volume	171
Issue number	10
DOIs	https://doi.org/10.7326/ACPJ201911190-053
Publication status	Published - 19 Nov 2019

Keywords

randomised controlled trial
thrombosis
percutaneous coronary intervention
Angioplasty
Antagonist Monotherapy
Dual Antiplatelet Therapy

Access to Document

10.7326/ACPJ201911190-053Licence: In Copyright

Cite this

@article{d08e5cc782c041cf89d5dc2dc31c3d42,

title = "After PCI and 3 mo of DAPT, P2Y12-inhibitor monotherapy was noninferior to DAPT at 12 mo",

abstract = "QuestionAfter percutaneous coronary intervention (PCI) and 3 months of dual-antiplatelet therapy (DAPT), is P2Y12-inhibitor monotherapy noninferior to continued DAPT?",

keywords = "randomised controlled trial, thrombosis, percutaneous coronary intervention, Angioplasty, Antagonist Monotherapy, Dual Antiplatelet Therapy",

author = "Alexander Gallus",

year = "2019",

month = nov,

day = "19",

doi = "10.7326/ACPJ201911190-053",

language = "English",

volume = "171",

pages = "JC53",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "AMERICAN COLLEGE OF PHYSICIANS",

number = "10",

}

TY - JOUR

T1 - After PCI and 3 mo of DAPT, P2Y12-inhibitor monotherapy was noninferior to DAPT at 12 mo

AU - Gallus, Alexander

PY - 2019/11/19

Y1 - 2019/11/19

N2 - QuestionAfter percutaneous coronary intervention (PCI) and 3 months of dual-antiplatelet therapy (DAPT), is P2Y12-inhibitor monotherapy noninferior to continued DAPT?

AB - QuestionAfter percutaneous coronary intervention (PCI) and 3 months of dual-antiplatelet therapy (DAPT), is P2Y12-inhibitor monotherapy noninferior to continued DAPT?

KW - randomised controlled trial

KW - thrombosis

KW - percutaneous coronary intervention

KW - Angioplasty

KW - Antagonist Monotherapy

KW - Dual Antiplatelet Therapy

UR - http://www.scopus.com/inward/record.url?scp=85075115131&partnerID=8YFLogxK

U2 - 10.7326/ACPJ201911190-053

DO - 10.7326/ACPJ201911190-053

M3 - Comment/debate

C2 - 31739336

AN - SCOPUS:85075115131

SN - 0003-4819

VL - 171

SP - JC53

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 10

ER -

After PCI and 3 mo of DAPT, P2Y12-inhibitor monotherapy was noninferior to DAPT at 12 mo

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this